Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical Neuropharmacology|May 15, 2014
Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs-an open-label studyRafael Stryjer, Dana Budnik, Tania Ebert, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2005
Reduced platelet vesicular monoamine transporter density in smoking schizophrenia patientsKarin Schwartz, Iulian Iancu, Rafael Stryjer, et al.
Journal of Addictive Diseases|April 17, 2020
Cognitive enhancement drug use among resident physicians: Prevalence and motivations for use - results from a surveyDafna Sara Rubin-Kahana, Ziv Rubin-Kahana, Maya Kuperberg, et al.
Archives of General Psychiatry|February 13, 2003
Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophreniaRael D Strous, Rachel Maayan, Raya Lapidus, et al.
The Israel Journal of Psychiatry and Related Sciences|March 10, 2005
DSM-IV self-report and subjective evaluation by psychiatrists in IsraelRael D Strous, Rafael Stryjer, Mordechai Weiss, et al.
Neuropsychobiology|July 30, 2003
Lower corneal temperature in neuroleptic-treated vs. drug-free schizophrenia patientsRoni Shiloh, Liron Bodinger, Nachum Katz, et al.
International Clinical Psychopharmacology|May 7, 2019
The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label studyDafna Sara Rubin-Kahana, Assaf Shelef, Abraham Weizman, et al.
Psychoneuroendocrinology|January 9, 2007
Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trialRael D Strous, Rafael Stryjer, Rachel Maayan, et al.
International Clinical Psychopharmacology|February 25, 2003
Amantadine as augmentation therapy in the management of treatment-resistant depressionRafael Stryjer, Rael D Strous, Ginette Shaked, et al.
Clinical Neuropharmacology|November 4, 2008
Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label studyRafael Stryjer, Baruch Spivak, Rael D Strous, et al.
Pageof 4